Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm June 1, 2022
Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity May 31, 2022
Evusheld retains neutralization activity against SARS-CoV-2 Omicron BA.4 and BA.5 variants May 26, 2022